TW
Thomas W. Beetham
DELAYED 1 MONTH
Chief Operating Officer
Viridian Therapeutics, Inc.\DE
Filings
2
Companies
1
Latest
Mar 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Viridian Therapeutics, Inc.\DE
Thomas W. Beetham
Chief Operating Officer
Option Exercise
—
9,409 sh
Mar 4 11:58 PM
Mar 3, 2026